[Türkçe]

Turkish Society of Cardiology Young Cardiologists Bulletin Year: 5 Number: 6 / 2022


Turkish Society of Cardiology
Young Cardiologists
President
Dr. Muzaffer Değertekin

Coordinator for the
Board of Directors

Dr. Ertuğrul Okuyan

Coordinator for the
Board of Directors

Dr. Can Yücel Karabay

Members
Dr. Adem Aktan
Dr. Gülşah Aktüre
Dr. Bayram Arslan
Dr. İnanç Artaç
Dr. Ahmet Oğuz Aslan
Dr. Görkem Ayhan
Dr. Ahmet Anıl Başkurt
Dr. Özkan Bekler
Dr. Oğuzhan Birdal
Dr. Yusuf Bozkurt Şahin
Dr. Serkan Bulgurluoğlu
Dr. Ümit Bulut
Dr. Veysi Can
Dr. Mustafa Candemir
Dr. Murat Çap
Dr. Göksel Çinier
Dr. Ali Çoner
Dr. Yusuf Demir
Dr. Ömer Furkan Demir
Dr. Murat Demirci
Dr. Ayşe İrem Demirtola Mammadli
Dr. Süleyman Çağan Efe
Dr. Mehmet Akif Erdöl
Dr. Kubilay Erselcan
Dr. Kerim Esenboğa
Dr. Duygu Genç
Dr. Kemal Göçer
Dr. Elif Güçlü
Dr. Arda Güler
Dr. Duygu İnan
Dr. Hasan Burak İşleyen
Dr. Muzaffer Kahyaoğlu
Dr. Sedat Kalkan
Dr. Yücel Kanal
Dr. Özkan Karaca
Dr. Ahmet Karaduman
Dr. Mustafa Karanfil
Dr. Ayhan Kol
Dr. Fatma Köksal
Dr. Mevlüt Serdar Kuyumcu
Dr. Yunus Emre Özbebek
Dr. Ahmet Özderya
Dr. Yasin Özen
Dr. Ayşenur Özkaya İbiş
Dr. Çağlar Özmen
Dr. Selvi Öztaş
Dr. Hasan Sarı
Dr. Serkan Sivri
Dr. Ali Uğur Soysal
Dr. Hüseyin Tezcan
Dr. Nazlı Turan
Dr. Berat Uğuz
Dr. Örsan Deniz Urgun
Dr. İdris Yakut
Dr. Mustafa Yenerçağ
Dr. Mehmet Fatih Yılmaz
Dr. Yakup Yiğit
Dr. Mehmet Murat Yiğitbaşı

Bulletin Editors
Dr. Muzaffer Değertekin
Dr. Bülent Mutlu
Dr. Süleyman Çağan Efe
Dr. Göksel Çinier
Dr. Duygu İnan
Dr. Sedat Kalkan

Contributors
Dr. Onur Akhan
Dr. Fatih Aksoy
Dr. Derya Baykiz
Dr.  İlyas Çetin
Dr. Uğur Ozan Demirhan
Dr. Elif Ayduk Gövdeli
Dr. Mustafa Ferhat Keten
Dr. Bengisu Keskin Meriç
Dr. İbrahim Halil Özdemir
Dr. Mehmet Arslan
Dr. Hüseyin Durak
Dr. Levent Pay


 



6--14

More precise algorithms are needed to select patients for invasive coronary testing (Dan-NICAD 2 trial)Türk Kardiyoloji Derneği Genç Kardiyologlar Bülteni - More precise algorithms are needed to select patients for invasive coronary testing (Dan-NICAD 2 trial) (Dr. Onur Akhan)

Reviewer: Dr. Onur Akhan

Name of the Study: More precise algorithms are needed to select patients for invasive coronary testing (Dan-NICAD 2 trial)

Published Congress: ESC 2022

Link : https://www.escardio.org/The-ESC/Press-Office/Press-releases/More-precise-algorithms-are-needed-to-select-patients-for-invasive-coronary-testing

Background:

Significant stenosis is not found in most patients referred to coronary CT angiography suspected of coronary artery disease, and myocardial perfusion imaging (MPI) techniques are recommended for revascularization in suspicious cases, according to the test result. While these imaging methods can quickly identify very severe stenosis and high-risk coronary artery disease, they are less sensitive to moderate and borderline FFR values. From this, it can be concluded that invasive methods can be avoided using a second imaging method. However, this finding also suggests that moderate stenosis may be missed.

Objective:

This study aims to compare the 3T cardiac magnetic resonance (CMR) and 82-rubidium positron emission tomography (Rb-PET) methods with the reference ICA-FFR process in patients with suspected obstructive stenosis in coronary CT angiography.

Methods:

A total of 1732 patients who underwent coronary CT angiography suspected of occlusive coronary artery disease were included in the study. The mean age is 59 years, and 57% of the patients are male. In addition, 26% of these patients were observed to have suspected stenosis (more than 50%), and these patients were randomized to both imaging modalities. A total of 372 patients who completed both imaging modalities were evaluated in the study.

Results:

Hemodynamically obstructive coronary artery disease was detected with ICA-FFR in 164 patients (44.1%). The sensitivity (64% - 59%) and specificity (89% - 84%) of Rb-PET were found to be higher than CMR (p=0.21 and p=0.08, respectively). Positive predictive and negative predictive values for both tests were found to be similar. The overall accuracy was higher in the Rb-PET method compared to CMR (78% vs. 73%; p=0.03). In addition, more high-risk patients were classified as abnormal in the Rb-PET method compared to CMR (96.8% vs. 77.4%; p=0.03). The sensitivity for severe stenosis, defined as the presence of more than 70% stenosis, was high in both methods (CMR: 83% vs. Rb-PET: 95%).

Conclusion:

CMR and Rb-PET methods have relatively moderate sensitivities and high specificities for predicting FFR results. Therefore, a perfusion test approach appears safe in almost all patients with severe disease (high-grade stenoses, left main and three-vessel disease). However, the relatively low sensitivities for estimating low FFR also means that there is often a discrepancy between these improved perfusion results and invasive FFR.

Interpretations:

The accuracy of coronary CTA needs to be improved with better CT image quality and perhaps more advanced image analysis, such as non-invasive FFR estimation and photon counting systems, thus avoiding further evaluation in more patients without a diagnosis of occlusive coronary artery disease. Finally, existing perfusion techniques can be further improved using quantitative perfusion measurements.


6--14

 2025 © Turkish Society of Cardiology.